Company Search:
Advanced Search
Sponsored Links
Biohit Oyj Company Snapshot
Biohit Oyj operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biohit Oyj with three other pharmaceutical manufacturers in Europe: RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS of Turkey (2015 sales of 33.96 million Turkish Liras [US$8.79 million] ), IDL Biotech AB of Sweden (28.52 million Swedish Kronor [US$3.16 million] ), and Epigenomics AG which is based in Germany (2.08 million Euro [US$2.20 million] of which 75% was Product sales (own and third party)).

Sales Analysis. Biohit Oyj reported sales of 6.05 million Euro (US$6.40 million) for the year ending December of 2015. This represents an increase of 38.7% versus 2014, when the company's sales were 4.36 million Euro. This was the third consecutive year of growth at Biohit Oyj.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biohit Oyj
  Stock Performance Chart for Biohit Oyj
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 6.33
(Figures in Euro)
1 Week -1.2%   13 Weeks 8.4%  
4 Weeks 6.4%   52 Weeks 9.7%  
Biohit Oyj Key Data:
  Ticker: BIOBV Country: Finland
  Exchanges: HEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 6,051,000
(Year Ending Jan 2016).
Employees: 42
  Currency: Euro Market Cap: 93,041,714
  Fiscal Yr Ends: December Shares Outstanding: 14,698,533
  Share Type: B Osake Closely Held Shares: 8,469,562
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.